Corporate Radar: Gujarat Themis Biosyn to go ex-dividend; Orchid Pharma board meeting and more
The board of Orchid Pharma will consider and approve, amongst other things, raising of funds and issuance of securities via Qualified Institutions Placement basis. The pharma stock is a multibagger and has surged nearly 18 times in the last five years.
